Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Pharmaceutical-grade materials HPLC tested for identity and purity Designed for consistency across research batches Produced exclusively for research use Intended Use & Compliance Notice This product is intended exclusively for qualified researchers, laboratories, and institutional research environments
AOD-9604 Pharmacokinetics & Metabolism Absorption & Distribution AOD-9604 exhibits unusual pharmacokinetic properties for a peptide, demonstrating activity via multiple administration routes in preclinical models: Oral bioavailability confirmed in pig and rodent studies, an uncommon characteristic for peptide compounds Rapid systemic distribution following intraperitoneal administration in mice (15-30 minutes) Following IV administration in pigs, AOD-9604 and degradation fragments appeared rapidly in plasma Oral administration showed slower kinetics but similar degradation product profiles Distribution studies using radiolabeled peptide (C-14-AOD9604) in rats revealed: Elevated concentrations in pineal body and thyroid tissues Distribution to all non-CNS tissues examined Minimal penetration of blood-brain barrier Tissue-specific accumulation patterns suggesting potential targeting mechanisms Metabolism & Elimination The metabolic fate of AOD-9604 involves rapid degradation through sequential N-terminal amino acid removal,: Plasma half-life of approximately 3 minutes following IV administration in pigs (compared to 21 minutes for full-length growth hormone) Sequential amino-terminal truncation represents the primary degradation pathway Principal metabolites identified in vivo include -2 amino acid and -3 amino acid fragments These truncated fragments retain some reduced in vitro anti-lipogenic activity A significant pharmacokinetic paradox exists: despite rapid plasma clearance (peptide undetectable at 56 minutes in spiked plasma studies), biological effects on body weight and fat metabolism persist for hours to days
How BPC-157 Supports Tissue Repair Think of BPC-157 as a skilled project manager coordinating a repair crew on a construction site
Bacteriostatic water for injection is defined as a sterile, non-pyrogenic aqueous solution containing 0.9% benzyl alcohol as a preservative per USP 2026 standards
Do lipotropic injections actually work for weight loss
The anaphylaxis study In a study published in the European Journal of Pharmacology, researchers induced anaphylactoid reactions in anesthetized mice and rats using intravenous dextran and white egg protein
